The rise of Sildenafil initially drove a boom for the drug industry, nevertheless recent changes present a murky outlook for those considering a stake. Lower-cost versions are eroding earnings, and continued patent https://rajanoxzg864746.develop-blog.com/49056854/the-blue-pill-and-big-pharma-a-volatile-play